Literature DB >> 12968673

Association of molecular variants, haplotypes, and linkage disequilibrium within the human vitamin D-binding protein (DBP) gene with postmenopausal bone mineral density.

Yoichi Ezura1, Toshiaki Nakajima, Mitsuko Kajita, Ryota Ishida, Satoshi Inoue, Hideyo Yoshida, Takao Suzuki, Masataka Shiraki, Takayuki Hosoi, Hajime Orimo, Mitsuru Emi.   

Abstract

UNLABELLED: Possible contribution of vitamin D-binding protein (DBP) gene for determination of BMD was tested by characterizing 13 SNPs in 384 adult Japanese women. When the effect of a specific single SNP was tested, five SNPs (-39C>T, IVS1+827C>T, IVS1+1916C>T, IVS1-1154A>G, and IVS11+1097G>C) correlated with BMD significantly at various levels. The chromosomal dosage of one haplotype (T-C-C-G-T-C in -39C>T, IVS1+827C>T, IVS1+1916C>T, IVS1-1154A>G, D432E, and IVS11+1097G>C) displayed significant correlation with adjusted radial BMD (r = 0.15, p = 0.008; n = 331). Multiple regression analyses revealed a most significant correlation with the combination of IVS1+827C>T and D432E (r2 = 0.029, p = 0.005). These results indicate a complex combined effect of several SNPs within the DBP gene that might underlie susceptibility to low radial BMD and osteoporosis.
INTRODUCTION: Osteoporosis results from the interplay of multiple environmental and genetic determinants. The gene encoding vitamin D-binding protein (DBP), a key factor for regulating calcium homeostasis through the vitamin D endocrine system, is a probable candidate for conferring susceptibility to osteoporosis.
METHODS: To test a possible contribution of the DBP gene for determination of bone mineral density (BMD) of adult women, we have characterized 13 single nucleotide polymorphisms (SNPs) within the DBP gene in DNA from 384 adult Japanese women and attempted to correlate specific SNPs with BMD. RESULTS AND
CONCLUSIONS: Sixteen major haplotypes accounted for 80% of the variations, indicating allelic complexity in this genomic region. Pairwise linkage disequilibrium (LD), measured by the D' and r2 statistics, demonstrated a general pattern of decline with increasing distance, but individual LD values within small genomic segments were diverse. Regression analysis for adjusted BMD revealed significant correlation with respect to five of them (-39C>T, IVS1+827C>T, IVS1+1916C>T, IVS1-1154A>G, and IVS11+1097G>C) at various levels. An intronic SNP (IVS11+1097G>C) with the highest significance of association (p = 0.006) showed significant LD with four SNPs located around the first exon (r2 values > 0.18, D' > 0.5). A non-synonymous coding SNP, D432E, showed a comparable level of correlation, but it was in a moderate LD only with IVS11+1097G>C. The chromosomal dosage of one haplotype (T-C-C-G-T-C in -39C>T, IVS1+827C>T, IVS1+1916C>T, IVS1-1154A>G, D432E and IVS11+1097G>C) estimated in each subject displayed significant correlation with adjusted radial BMD (r = 0.15, p = 0.008; n = 331). Furthermore, multiple regression analyses revealed that the most significant correlation was achieved for the combination of IVS1+827C>T and D432E (r2 = 0.029, p = 0.005). These results indicate a complex combined effect of several SNPs within the DBP gene that might underlie susceptibility to low radial BMD and osteoporosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12968673     DOI: 10.1359/jbmr.2003.18.9.1642

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  18 in total

Review 1.  Genetic aspects of osteoporosis.

Authors:  Takayuki Hosoi
Journal:  J Bone Miner Metab       Date:  2010-08-10       Impact factor: 2.626

Review 2.  Molecular genetic studies of gene identification for osteoporosis: a 2004 update.

Authors:  Yong-Jun Liu; Hui Shen; Peng Xiao; Dong-Hai Xiong; Li-Hua Li; Robert R Recker; Hong-Wen Deng
Journal:  J Bone Miner Res       Date:  2006-10       Impact factor: 6.741

3.  Association of GC Variants with Bone Mineral Density and Serum VDBP Concentrations in Mexican Population.

Authors:  Berenice Rivera-Paredez; Alberto Hidalgo-Bravo; Guadalupe León-Reyes; Bárbara Antuna-Puente; Yvonne N Flores; Jorge Salmerón; Rafael Velázquez-Cruz
Journal:  Genes (Basel)       Date:  2021-07-29       Impact factor: 4.096

4.  Vitamin D-binding protein gene microsatellite polymorphism influences BMD and risk of fractures in men.

Authors:  Z H Al-oanzi; S P Tuck; S S Mastana; G D Summers; D B Cook; R M Francis; H K Datta
Journal:  Osteoporos Int       Date:  2007-11-24       Impact factor: 4.507

Review 5.  Basic and clinical aspects of osteoporosis in inflammatory bowel disease.

Authors:  Lorena Rodríguez-Bores; Josué Barahona-Garrido; Jesús K Yamamoto-Furusho
Journal:  World J Gastroenterol       Date:  2007-12-14       Impact factor: 5.742

Review 6.  Genetics of osteoporosis: accelerating pace in gene identification and validation.

Authors:  Wen-Feng Li; Shu-Xun Hou; Bin Yu; Meng-Meng Li; Claude Férec; Jian-Min Chen
Journal:  Hum Genet       Date:  2009-12-12       Impact factor: 4.132

7.  Lack of association of bone morphogenetic protein 2 gene haplotypes with bone mineral density, bone loss, or risk of fractures in men.

Authors:  Satya S Varanasi; Stephen P Tuck; Sarabjit S Mastana; Elaine Dennison; Cyrus Cooper; Josephine Vila; Roger M Francis; Harish K Datta
Journal:  J Osteoporos       Date:  2011-10-13

8.  Vitamin D binding protein genotype and osteoporosis.

Authors:  Yue Fang; Joyce B J van Meurs; Pascal Arp; Johannes P T van Leeuwen; Albert Hofman; Huibert A P Pols; André G Uitterlinden
Journal:  Calcif Tissue Int       Date:  2009-06-02       Impact factor: 4.333

Review 9.  Roles of vitamin D in amyotrophic lateral sclerosis: possible genetic and cellular signaling mechanisms.

Authors:  Khanh vinh quốc Long; Lan Thi Hoàng Nguyễn
Journal:  Mol Brain       Date:  2013-04-09       Impact factor: 4.041

Review 10.  Common variants of the vitamin D binding protein gene and adverse health outcomes.

Authors:  Suneil Malik; Lei Fu; David James Juras; Mohamed Karmali; Betty Y L Wong; Agnes Gozdzik; David E C Cole
Journal:  Crit Rev Clin Lab Sci       Date:  2013-02-22       Impact factor: 6.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.